nopzon
.com
Bluesky Explorer
Search
Home
Trending
Search
Advertisement · 728 × 90
#
Hashtag
#Ligufalimab
Advertisement · 728 × 90
Thiard News@F4F
@newsen.bsky.social
7 months ago
Akeso's Ligufalimab Secures FDA Orphan Drug Designation for AML Treatment
Akeso's novel IgG4 monoclonal antibody, ligufalimab, has received FDA Orphan Drug Designation for acute myeloid leukemia, aiming to provide better treatment options.
Akeso's Ligufalimab Secures FDA Orphan Drug Designation for AML Treatment
#AML
#Akeso
#Ligufalimab
0
0
0
0